CD38 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD38 monoclonal antibodies for various research applications. CD38 monoclonal antibodies are effective tools for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD38 is a multifunctional enzyme that plays a critical role in cell signaling and immune response regulation. It is involved in the synthesis of cyclic ADP-ribose, a molecule that regulates calcium signaling in cells, and is also implicated in various physiological processes, including lymphocyte activation and differentiation. CD38 has been identified as a key factor in several diseases, including cancer and autoimmune disorders. Research has shown that CD38 expression levels can serve as important diagnostic and prognostic markers in multiple myeloma and other hematological malignancies. Understanding CD38's role in immune cell function has led to significant developments in targeted therapies. CD38 monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance their understanding of cellular processes and contribute to the development of new therapeutic strategies.